Abstract
Systemic therapy of psoriasis with biologics or cyclosporine requires combined follow-up of patients by hospitals and dermatologists in private practice. Initiation of therapy and the laboratory examinations required before starting treatment are carried out in a hospital setting, and subsequent follow-up may be carried out by a dermatologist in private practice. Successful combined follow-up depends on certain key points, chiefly good knowledge by the independent dermatologist of the systemic therapies available for psoriasis, and smooth working of the hospital-dermatologist interface. It is essential to develop training and information tools in order to optimise joint therapy. This may also be formalised by the creation of a healthcare network as provided for in French legislation (law of 4 March 2002).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
